OCUL
Price:
$8.83
Market Cap:
$1.39B
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retin...[Read more]
Industry
Biotechnology
IPO Date
2014-07-25
Stock Exchange
NASDAQ
Ticker
OCUL
According to Ocular Therapeutix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.04B. This represents a change of 46.81% compared to the average of 705.74M of the last 4 quarters.
The mean historical Enterprise Value of Ocular Therapeutix, Inc. over the last ten years is 296.85M. The current 1.04B Enterprise Value has changed 34.80% with respect to the historical average. Over the past ten years (40 quarters), OCUL's Enterprise Value was at its highest in in the December 2020 quarter at 1.29B. The Enterprise Value was at its lowest in in the June 2016 quarter at 89.90M.
Average
296.85M
Median
196.35M
Minimum
104.72M
Maximum
1.09B
Discovering the peaks and valleys of Ocular Therapeutix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 858.91%
Maximum Annual Enterprise Value = 1.09B
Minimum Annual Increase = -60.73%
Minimum Annual Enterprise Value = 104.72M
Year | Enterprise Value | Change |
---|---|---|
2023 | 243.61M | 36.86% |
2022 | 178.00M | -58.34% |
2021 | 427.28M | -60.73% |
2020 | 1.09B | 492.13% |
2019 | 183.74M | 50.08% |
2018 | 122.42M | 16.91% |
2017 | 104.72M | -45.01% |
2016 | 190.42M | -5.87% |
2015 | 202.29M | -11.29% |
2014 | 228.03M | 858.91% |
The current Enterprise Value of Ocular Therapeutix, Inc. (OCUL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
282.96M
5-year avg
424.12M
10-year avg
296.85M
Ocular Therapeutix, Inc.’s Enterprise Value is greater than CytomX Therapeutics, Inc. (39.67M), greater than Assembly Biosciences, Inc. (68.59M), greater than Spero Therapeutics, Inc. (-8426888.00), greater than Achilles Therapeutics plc (-38865958.00), greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Amylyx Pharmaceuticals, Inc. (291.98M), greater than Acumen Pharmaceuticals, Inc. (139.19M), greater than Inozyme Pharma, Inc. (202.73M), greater than X4 Pharmaceuticals, Inc. (38.44M), greater than Mereo BioPharma Group plc (496.22M), greater than PDS Biotechnology Corporation (53.10M), greater than HOOKIPA Pharma Inc. (-36166707.00), greater than Day One Biopharmaceuticals, Inc. (963.46M),
Company | Enterprise Value | Market cap |
---|---|---|
39.67M | $69.65M | |
68.59M | $95.60M | |
-8426888.00 | $63.24M | |
-38865958.00 | $43.57M | |
222.97M | $491.80M | |
291.98M | $361.25M | |
139.19M | $142.39M | |
202.73M | $180.51M | |
38.44M | $57.64M | |
496.22M | $575.61M | |
53.10M | $78.19M | |
-36166707.00 | $20.76M | |
963.46M | $1.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocular Therapeutix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ocular Therapeutix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ocular Therapeutix, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ocular Therapeutix, Inc. (OCUL)?
What is the 3-year average Enterprise Value for Ocular Therapeutix, Inc. (OCUL)?
What is the 5-year average Enterprise Value for Ocular Therapeutix, Inc. (OCUL)?
How does the current Enterprise Value for Ocular Therapeutix, Inc. (OCUL) compare to its historical average?